Premium Information is available for this item - Upgrade for $1 a day
6505-00-271-9215
Levothyroxine Sodium For Injection
6505002719215 002719215 SYNTHR0IDINJECTI0N 48-1300-21
INC: 32146 Levothyroxine Sodium For Injection
November 2023
7

Marketplace 6505-00-271-9215
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-271-9215 5+ Documents (More...)
RQST NE Updated Every Day 6505-00-271-9215 RQST Updated Every Day 6505-00-271-9215 RQST NE Related
Levothyroxine Sodium For Injection 002719215 235-8562 Sodium For Injection 152358562 002719215
Levothyroxine Sodium For Injection 002719215 For Injection 002719215 https//www.nsnlookup.com https
015717176 Injection 015717176 Injection 010935457 65/fsc https Levothyroxine Sodium For Injection 002719215
Levothyroxine Sodium For Injection 002719215 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505
Levothyroxine Sodium For Injection 152358562 it 6505-15-235-8562 /fsg-65/fsc-6505/it 6505-15 https Injection 002719215
Levothyroxine Sodium For Injection 002719215 Levothyroxine Levothyroxine Sodium For Injection 002719215
Injection 016979775 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-231 Levothyroxine Sodium For Injection 002719215
Levothyroxine Sodium For Injection 002719215 65/fsc-6505/us 6505-00-271-9215 Levothyroxine Sodium
For Injection 002719215 Sodium For Injection 016151662 Injection 152358562 Related to 6505-00-271-9215
Restrictions 6505-00-271-9215
6505-00-271-9215 is a Levothyroxine Sodium For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-271-9215
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-271-9215
- Part Number
- Manufacturer
- Status
- SYNTHR0IDINJECTI0N
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
- 48-1300-21
- 04687 - Baxter Healthcare Corp (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6505-00-271-9215
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 500.000 Usp Units Levothyroxine Sodium Active Ingredient
- Physical Form [AGXW]
- Powder
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500 Micrograms
Similar Supply Items to 6505-00-271-9215


















Freight Information 6505-00-271-9215
6505-00-271-9215 has freight characteristics.. 6505-00-271-9215 has a variance between NMFC and UFC when transported by rail and the description should be consulted.